Effect of Staphylococcus Aureus and Streptococcus beta-haemolytic Supernatants’ on Leishmania Major Promastigotes Viability: An In Vitro Study
Publish Year: 1396
نوع سند: مقاله ژورنالی
زبان: English
View: 50
This Paper With 8 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_JIML-4-3_006
تاریخ نمایه سازی: 14 مرداد 1402
Abstract:
Background and Aims: Leishmaniasis is an intracellular protozoan- parasitic disease, the common vector of transmission. Both zoonotic and anthroponotic cutaneous leishmaniasis (CL) are endemic in different foci. With regard to the cutaneous form, ۱.۰-۱.۵ million cases were reported annually with ۹۰% of the cases. Although antimony-containing compounds that are the main drugs used to treat Leishmaniasis has been recommended for CL treatment by the World Health Organization, but there are some restrictions in this case, including high expense, side effects, frequent injections need, and incomplete efficacy. The current research was conducted the effect of Staphylococcus aureus and Streptococcus beta-haemolytic Supernatants’ on Leishmania major promastigotes (PMs) viability: an in vitro study.
Materials and Methods: Staphylococcus aureus and Streptococcus beta-haemolytic cultured for preparing supernatant, then Leishmania (L) major strain [MRHO/IR/۷۵/ER] PMs cultured in Novy-Nicolle-Mac Neal (NNN) and roswell park memorial institute ۱۶۴۰ media. The cell proliferation of enzyme-linked immunosorbent assay, BrdU (Chemiluminescent) was performed as described by Roche Diagnostics. The mean of the viability PMs of Leishmania (L) major strain [MRHO/IR/۷۵/ER] in culture according to Staphylococcus aureus and Streptococcus beta-haemolytic supernatant, Glocantime concentrations and in the control group (Glocantime) was obtained.
Results: It was shown that there was a statistical significant difference among Staphylococcus aureus and Streptococcus beta-haemolytic supernatant inhibits growth of Leishmania (L) major strain [MRHO/IR/۷۵/ER] PMs with the control group (p<۰.۰۵) .
Conclusions: These exciting results suggest that Staphylococcus aureus and Streptococcus beta-haemolytic Supernatants have significant therapeutic potential as novel anti-leishmanial.
Keywords:
Authors
علی فتاحی بافقی
Department of Parasitology and Mycology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
بنفشه گودیانی
Department of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
محمد حسین مصدق
School of Pharmacy, Shahid Sadoughi University of Medical Sciences, Shohadaye Gomnam Blvd, Safaeeyeh, Yazd, Iran
عارفه دهقانی
School of Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
مریم ساده
Department of Laboratory Technology, Faculty of Paramedicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :